The Worldwide Media, Sera and Reagents in Biotechnology Industry is Expected to Reach $7.4 Billion by 2026

Dublin, Oct. 12, 2021 (GLOBE NEWSWIRE) -- The "Global Markets for Media, Sera and Reagents in Biotechnology" report has been added to's offering.

The current report offers a detailed picture of media, sera and reagents in biotechnology. This report highlights the current and future market potential for media, sera and reagents in biotechnology and provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities and trends in the market.

This report also covers market projections through 2026 and key market players.

  • The global market for media, sera and reagents in biotechnology is estimated to grow from $5.0 billion in 2021 to $7.4 billion by 2026 at a compound annual growth rate (CAGR) of 7.9% of during the forecast period of 2021-2026.
  • North American market for media, sera and reagents in biotechnology is estimated to grow from $1.7 billion in 2021 to $2.3 billion by 2026 at a CAGR of 5.9% of during the forecast period of 2021-2026.
  • Asia-Pacific market for media, sera and reagents in biotechnology is estimated to grow from $1.2 billion in 2021 to $1.9 billion by 2026 at a CAGR of 9.5% of during the forecast period of 2021-2026.

The report details market shares of media, sera and reagents in cell culture. Market analysis in the media segment is divided into specialty media and classical media based on composition.

Based on formulation, the media are divided into powdered media and ready-to-use liquid media. Based on serum component, media are segmented into serum-free media and serum-requiring media. The market for sera is segmented based on the source of serum into fetal bovine serum and other sera which includes sera from animal sources such as goats, porcine, rabbits, etc.

The reagents market is segmented into reagents: biological response modifiers, cell dissociation reagents and others (amino acids, antibiotics, etc.). By geography, the market has been segmented into North America, Europe, the Asia-Pacific region, Middle East and Africa and South America. North America includes the U.S., Canada and Mexico, Europe includes Germany, the U.K., France, Italy, Spain and the Rest of Europe. The Asia-Pacific region includes China, India, Japan, Australia, New Zealand and the Rest of Asia-Pacific.

Report Includes:

  • 61 data tables and 44 additional tables
  • An updated review of current and future global markets for media, sera and reagents in the cell culture industry and its sub-segments
  • Analyses of the global market trends, with data from 2019-2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through 2026
  • Discussion of major factors driving the growth of this market, industry structure, regulatory scenario, and penetration of technologies related to media, sera, and reagents in biotechnology
  • Estimation of the market size and market forecast for global media, sera, and reagents in biotechnology, and corresponding market share analysis by product type, end use, and region
  • Country specific data and market value analysis for the U.S., Canada, Mexico, Germany, UK, France, Italy, Spain, Japan, China, India, Australia and New Zealand, the Middle East and Africa
  • Highlights of emerging technology trends, opportunities and gaps estimating current and future demand for cell culture products; and impact analysis of COVID-19 on the progress of this market
  • A relevant patent analysis with significant allotments of patent issued for cell culture media, sera and reagents in biotechnology across each major category
  • Insight into the recent industry strategies, M&A deals of the major players operating within the global market; their key competitive landscape and company share analysis
  • Profile descriptions of the leading industry players, including Bio-Techne, Corning Inc., Fujifilm Holdings Corp., GE Healthcare, Merck KGaA and Thermo Fisher Scientific Inc.

Cell culture is the in vitro cultivation of cells in a controlled environment. Cell culture is gaining importance in biopharmaceutical industries with the growing demand for cell culture techniques in drug discovery and the production of biotherapeutics. Cell culture is used in academic research institutes to understand the physiology and biochemistry of cells.

Media, sera and reagents play an important role in the success of cell culture technology. The growing demand for novel therapeutics for the treatment of chronic disease and extensive research activities in regenerative medicine are anticipated to create high growth for media, sera and reagents during the forecast period.

The intent of this study is to provide readers with detailed information regarding cell culture, along with factors influencing market and key developments, with the goal of enabling decision-making regarding expansion and penetration in this market.

This report seeks to address the critically important topics of changing market dynamics, emerging players and technologies, strategies for accessing emerging markets and specific disease segments and geographies.

Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

  • Industry Definitions
  • Historical Background of the Evolution of Cell Culture
  • Types of Cell Culture
  • Primary Culture
  • Secondary Culture
  • Morphology of Cells in Culture
  • Cell Culture Contamination and Quality Control
  • Cell Culture Contamination
  • Quality Controls in Cell Culture
  • Basic Components of Culture Media
  • Buffering Systems
  • Phenol Red
  • Inorganic Salts
  • Amino Acids
  • Carbohydrates
  • Proteins and Peptides
  • Fatty Acids and Lipids
  • Vitamins
  • Trace Elements
  • Media Supplements
  • Antibiotics
  • Serum
  • Cell Culture Applications

Chapter 4 Impact of COVID-19 Pandemic

  • Introduction
  • Outbreak
  • Impact of COVID-19 on Markets

Chapter 5 Market Dynamics

  • Market Drivers
  • Growing Demand
  • Technological Advancements
  • Expansion of Cell Cultures
  • R&D and Regenerative Medicines
  • Market Restraints
  • Ethical Issues and Regulatory Constraints
  • Lack of Skilled Technicians and Poor Infrastructure
  • Market Opportunities
  • Rising Demand for 3D Cell Cultures
  • Drug Discovery and Growing CRO

Chapter 6 Market Breakdown by Product Type

  • Global Market for Media, Sera and Reagents in Biotechnology, by Product Type
  • Reagents
  • Biological Response Modifiers (BRMs)
  • Cell Dissociation Reagents
  • Other Reagents
  • Market Size and Forecast
  • Media
  • Based on Serum
  • Based on Formulation
  • Based on Composition
  • Market Size and Forecast
  • Sera
  • Bovine Sera/Fetal Bovine Sera
  • Other Sera
  • Market Size and Forecast

Chapter 7 Market Breakdown by End Use

  • Global Market for Media, Sera and Reagents in Biotechnology, by End Use
  • Production
  • Research
  • Contract
  • Other End Uses

Chapter 8 Market Breakdown by Region

  • Global Market for Media, Sera and Reagents in Biotechnology, by Region
  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East and Africa

Chapter 9 Regulatory Scenarios

  • Introduction
  • Biological License Applications
  • Biological Administrative Actions
  • Recalls
  • Serum Regulatory Scenario

Chapter 10 Competitive Landscape

  • Overview
  • Company Market Shares of Media, Sera and Reagents in Biotechnology
  • Media
  • Sera
  • Reagents

Chapter 11 Patent Analysis

  • Patents Granted by Year
  • Patents Granted by Type
  • Patents Granted by Company/Patent Holder
  • Patents Granted by Assignee's Country
  • Patents Granted by Assignee Type

Chapter 12 Company Profiles

  • Athena Environmental Sciences Inc.
  • Bio-Techne
  • Becton, Dickinson And Co. (Bd)
  • Biowest
  • Bovogen Biologicals Pty Ltd.
  • Cell Culture Technologies Llc
  • Corning Inc.
  • Fujifilm Holdings Corp.
  • General Electric Co.
  • Gemini Bio-Products Inc.
  • Lonza Group
  • Merck Millipore
  • Miltenyi Biotec
  • Peprotech Inc.
  • Promocell Gmbh
  • Reprocell Inc.
  • Thermo Fisher Scientific Inc.

For more information about this report visit


Contact Data